OM
IMMU

Opaleye Management’s Immunomedics Inc IMMU Stock Holding History

Opaleye Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-898,800
Closed -$14.5M – 47
2017
Q4 		$14.5M Hold
898,800
– – 4.65% 5
2017
Q3 		$12.6M Sell
898,800
-1,200
-0.1% -$12K 4.44% 4
2017
Q2 		$7.95M Sell
900,000
-60,000
-6% -$421K 3.32% 7
2017
Q1 		$6.21M Buy
+960,000
New +$4.86M 3.09% 9
2016
Q4 		– Sell
-1,200,000
Closed -$3.9M – 50
2016
Q3 		$3.9M Sell
1,200,000
-100,000
-8% -$280K 2.04% 20
2016
Q2 		$3.02M Sell
1,300,000
-25,000
-2% -$83.5K 2.01% 18
2016
Q1 		$3.31M Buy
1,325,000
+1,035,000
+357% +$2.33M 2.07% 23
2015
Q4 		$890K Buy
+290,000
New +$809K 0.37% 49

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Opaleye Management's IMMU Position: Q1 2018 in Review

Opaleye Management sold out of Immunomedics Inc (IMMU) in Q1 2018, closing a stake of 898,800 shares — an estimated $14.5M sold.

Opaleye Management first reported a position in IMMU in Q4 2015 and held it in 8 quarters. The position peaked at $14.5M in Q4 2017. 168 funds tracked by Wall St. Rank hold IMMU as of Q1 2018.

  • Opaleye Management reported no remaining Immunomedics Inc position as of Q1 2018 after selling out during the quarter.
  • Opaleye Management sold 898,800 Immunomedics Inc shares in Q1 2018, an estimated $14.5M.
  • Opaleye Management first reported a position in Immunomedics Inc in Q4 2015 and held it in 8 quarters.
  • Opaleye Management's Immunomedics Inc position peaked at $14.5M in Q4 2017.
  • 168 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2018.

Based on Opaleye Management's 13F filing for Q1 2018, filed 14 May 2018.